Moderna (MRNA) had the highest return in March 2023 by a mid-cap US stock in the S&P 500 (GSPC), returning 11%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Moderna (MRNA) | March 2023 | 10.98% |
Align Technology (ALGN) | March 2023 | 8.66% |
Paycom Soft (PAYC) | March 2023 | 5.41% |
Campbell’s (CPB) | March 2023 | 5.25% |
Smith AO (AOS) | March 2023 | 5.17% |
Interpublic Group of Companies (IPG) | March 2023 | 5.11% |
Henry Schein (HSIC) | March 2023 | 4.83% |
Lamb Weston (LW) | March 2023 | 4.1% |
ConAgra Foods (CAG) | March 2023 | 3.61% |
MGM Resorts International (MGM) | March 2023 | 3.3% |
Bio-Techne (TECH) | March 2023 | 2.64% |
Baxter International (BAX) | March 2023 | 2.3% |
FactSet Research Systems (FDS) | March 2023 | 0.79% |
LKQ (LKQ) | March 2023 | 0.21% |
DaVita HealthCare Partners (DVA) | March 2023 | -0.58% |
Molson Coors Brewing (TAP) | March 2023 | -1.51% |
Mohawk Industries (MHK) | March 2023 | -2.15% |
Molina Healthcare (MOH) | March 2023 | -2.23% |
EPAM Systems (EPAM) | March 2023 | -2.6% |
Pool (POOL) | March 2023 | -2.99% |
APA (APA) | March 2023 | -5.97% |
Match (MTCH) | March 2023 | -7.65% |
Charles River Laboratories (CRL) | March 2023 | -7.7% |
Norwegian Cruise Line (NCLH) | March 2023 | -9.49% |
Generac (GNRC) | March 2023 | -10.74% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
